Clinical Trials Browser

B-cell Malignancies × itacitinib × 30 days × Clear all

NCT01905813 2026-05-11

Study of INCB040093 in Subjects With Previously Treated B-Cell Malignancies

Phase 1 Completed

B-cell Malignancies